Evidence map›Paper›PMID 7509451›Full record

ArticleMolecular and cellular biology1994

Growth hormone and erythropoietin differentially activate DNA-binding proteins by tyrosine phosphorylation.

D S Finbloom, E F Petricoin, R H Hackett, M David, G M Feldman, K Igarashi, E Fibach, M J Weber, M O Thorner, C M Silva

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 1994. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 90 citations in OpenAlex.

  1. Review
  2. Modeling the Hematopoietic Landscape.Frontiers in cell and developmental biology · 2019
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15.Proceedings of the National Academy of Sciences of the United States of America · 1995
    Article
  11. Article
  12. Signaling through the interleukin 2 receptor beta chain activates a STAT-5-like DNA-binding activity.Proceedings of the National Academy of Sciences of the United States of America · 1995
    Article
  13. Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes.Proceedings of the National Academy of Sciences of the United States of America · 1995
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

D S FinbloomDivision of Cytokine Biology, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland 20892.
E F Petricoin
R H Hackett
M David
G M Feldman
K Igarashi
E Fibach
M J Weber
M O Thorner
C M Silva
National Institute of Diabetes and Digestive and Kidney Diseases · US

Funding

IMMUNE RESPONSES BY GUT-ASSOCIATED LYMPHOID TISSUEF33DK008942 · NIDDK · UNIVERSITY OF VIRGINIA CHARLOTTESVILLE · PI ROCHE, JAMES K. · 1994 to 1994
–
NIDDK NIH HHS DK08942
6 · The paper itself

Abstract

Binding of growth hormone (GH) and erythropoietin (EPO) to their respective receptors results in receptor clustering and activation of tyrosine kinases that initiate a cascade of events resulting not only in the rapid tyrosine phosphorylation of several proteins but also in the induction of early-response genes. In this report, we show that GH and EPO induce the tyrosine phosphorylation of cellular proteins with molecular masses of 93 kDa and of 91 and 84 kDa, respectively, and that these proteins form DNA-binding complexes which recognize an enhancer that has features in common with several rapidly induced genes such as c-fos. Assembly of the protein complexes required tyrosine phosphorylation, which occurred within minutes after addition of ligand. The activated complexes translocated from the cytoplasm to the nucleus. The protein activated by GH is antigenically similar to p91, a protein common to several transcription complexes that are activated by interferons and other cytokines. In contrast, the proteins activated by EPO are distinct from p91. These findings establish the outlines for a cytokine-induced intracellular signaling pathway, which begins with ligand-induced receptor clustering that activates one or more tyrosine kinases. These data are the first to demonstrate that GH- and EPO-activated tyrosine-phosphorylated proteins can specifically recognize a well-defined enhancer and therefore provide a mechanism for rapidly transducing signals from the membrane to the nucleus.

Indexed as

Enhancer Elements, GeneticGene Expression RegulationBase SequenceCell LineDeoxyribonucleoproteinsDNA-Binding ProteinsErythropoietinGrowth HormoneHumansIn Vitro TechniquesMolecular Sequence DataMolecular WeightOligodeoxyribonucleotidesPhosphoproteinsPhosphotyrosineProtein-Tyrosine KinasesDeoxyribonucleoproteinsDNA-Binding ProteinsErythropoietinGrowth HormoneOligodeoxyribonucleotidesPhosphoproteinsPhosphotyrosineProtein-Tyrosine KinasesRNA, MessengerTyrosine

Identifiers

PMID7509451
PMCPMC358571
OpenAlexW2106226302

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.